Retina (Philadelphia, Pa.)
via Europe PMC
TELEMANIPULATED ROBOT-ASSISTED VITREORETINAL SURGERY: Safety and Effectiveness of the Luca System in Robotically Performed Core Vitrectomy in ERM or Macular Hole Surgical Treatment.
Nerinckx F, Van Slycken M, Van Puyvelde J, Leroy B.
AI summary β for doctors, generated from the abstract only
The Luca telemanipulated robot performed core vitrectomy safely in the first seven patients with epiretinal membrane or macular hole.
What was studied
Prospective single-arm first-in-human study of 7 patients (6 ERM, 1 macular hole) at Ghent University Hospital, where the robot induced PVD and performed core vitrectomy before manual completion.
Key findings
- No device-related or serious adverse events, and no iatrogenic retinal tears or hemorrhages from the robot
- Robotic portion completed as planned in 6 of 7 (85.7%)
- 5 of 7 patients (71.4%) gained distance acuity at 3 months
Clinical relevance
Early evidence that bimanual robotic systems could be feasible for vitreoretinal surgery.
Who should care
Limitations
Seven patients, no comparator, short follow-up, limited to the core vitrectomy step.
No practice change; this is feasibility data and larger trials are needed.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates β verify against the original source before acting on it.
Abstract
Purpose
To evaluate the initial safety and feasibility of the Luca system, a telemanipulated robotic system with bimanual capabilities, used to perform a core vitrectomy during surgical treatment of epiretinal membrane or macular hole.
Methods
This was a prospective, single-arm, first-in-human study conducted at Ghent University Hospital in Belgium. Seven patients (mean age 71.0 Β± 11.5 years) scheduled for vitreoretinal surgery for epiretinal membrane (n = 6) or macular hole (n = 1) were enrolled between February and June 2024. The Luca system was used to create a posterior vitreous detachment and to perform a core vitrectomy, after which the remainder of the surgery (e.g., membrane peeling) was completed manually. The primary safety end point was the incidence and severity of device-related adverse event (AEs). Secondary end points included the proportion of subjects with iatrogenic retinal tears and changes in best-corrected distance visual acuity and best-corrected near visual acuity.
Results
All surgeries were completed without serious safety incidents, and no device-related AEs or serious AEs were reported. No accidental retinal touches, hemorrhages, or iatrogenic retinal tears related to the robotic system occurred. In six of seven patients (85.7%), the robotic-assisted part of the procedure was successfully completed according to preoperative planning. At 3 months, five of seven patients (71.4%) had a best-corrected distance visual acuity gain.
Conclusion
The initial clinical experience with the Luca robotic system demonstrates a favorable safety, feasibility, and performance profile for vitreoretinal surgery in patients with acquired maculopathies. The safety profile seems comparable with that of manual surgery.
DOI
10.1097/iae.0000000000004958
PMID
42566755
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed